Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6563) 6563
Book Review (2332) 2332
Publication (638) 638
Book Chapter (101) 101
Conference Proceeding (51) 51
Book / eBook (8) 8
Dissertation (4) 4
Paper (4) 4
Government Document (3) 3
Magazine Article (2) 2
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5404) 5404
humans (4872) 4872
oncology (2485) 2485
cancer (2272) 2272
female (2221) 2221
male (1861) 1861
middle aged (1507) 1507
metastasis (1396) 1396
biomarkers (1319) 1319
aged (1251) 1251
prognosis (1233) 1233
animals (1122) 1122
circulating tumor-cells (1115) 1115
adult (1091) 1091
tumors (1047) 1047
research (1006) 1006
genetic aspects (1000) 1000
mutation (970) 970
diagnosis (937) 937
analysis (923) 923
circulating micrornas (872) 872
biomarkers, tumor - genetics (861) 861
circulating tumor dna (848) 848
breast cancer (847) 847
biomarkers, tumor - blood (844) 844
microrna (835) 835
expression (823) 823
plasma (788) 788
care and treatment (787) 787
gene expression (784) 784
dna (777) 777
neoplastic cells, circulating - pathology (771) 771
breast-cancer (730) 730
deoxyribonucleic acid--dna (715) 715
peripheral-blood (693) 693
cell biology (666) 666
circulating tumor cells (646) 646
blood (643) 643
health aspects (643) 643
liquid biopsy (635) 635
development and progression (622) 622
patients (600) 600
micrornas - genetics (590) 590
aged, 80 and over (570) 570
polymerase chain reaction (570) 570
review (559) 559
neoplastic cells, circulating - metabolism (553) 553
chemotherapy (548) 548
biomarker (538) 538
medicine (526) 526
micrornas (517) 517
article (516) 516
lung-cancer (514) 514
biochemistry & molecular biology (512) 512
lung cancer (507) 507
survival (507) 507
colorectal cancer (485) 485
neoplastic cells, circulating (479) 479
colorectal-cancer (478) 478
mirna (471) 471
serum (469) 469
multidisciplinary sciences (463) 463
cell line, tumor (447) 447
medicine, research & experimental (445) 445
dna methylation (441) 441
prostate cancer (438) 438
cells (435) 435
research article (432) 432
dna, neoplasm - blood (428) 428
neoplasm staging (427) 427
proteins (425) 425
pathology (422) 422
neoplasms - genetics (419) 419
biopsy (415) 415
gene expression regulation, neoplastic (408) 408
cell-free dna (407) 407
case-control studies (406) 406
sensitivity and specificity (406) 406
metastases (404) 404
breast neoplasms - pathology (403) 403
genes (400) 400
medical prognosis (395) 395
breast neoplasms - genetics (391) 391
medical research (391) 391
neoplasm metastasis (386) 386
apoptosis (385) 385
lung neoplasms - genetics (383) 383
mice (381) 381
polymerase-chain-reaction (380) 380
genetic research (378) 378
micrornas - blood (373) 373
carcinoma (358) 358
reverse transcriptase polymerase chain reaction (353) 353
studies (353) 353
therapy (350) 350
gene-expression (346) 346
physiological aspects (346) 346
genomics (341) 341
cancer therapies (338) 338
biology (335) 335
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6561) 6561
German (16) 16
Chinese (10) 10
French (9) 9
Japanese (6) 6
Korean (3) 3
Russian (2) 2
Finnish (1) 1
Hungarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next-generation sequencing of cell-free circulating tumor DNA
by Thompson, Jeffrey C and Yee, Stephanie S and Troxel, Andrea B and Savitch, Samantha L and Fan, Ryan and Balli, David and Lieberman, David B and Morrissette, Jennifer D and Evans, Tracey L and Bauml, Joshua and Aggarwal, Charu and Kosteva, John A and Alley, Evan and Ciunci, Christine and Cohen, Roger B and Bagley, Stephen and Stonehouse-Lee, Susan and Sherry, Victoria E and Gilbert, Elizabeth and Langer, Corey and Vachani, Anil and Carpenter, Erica L
Clinical Cancer Research, ISSN 1078-0432, 12/2016, Volume 22, Issue 23, pp. 5772 - 5782
Purpose: The expanding number of targeted therapeutics for non-small cell lung cancer (NSCLC) necessitates real-time tumor genotyping, yet tissue biopsies are... 
TYROSINE KINASE INHIBITORS | KRAS MUTATIONS | HETEROGENEITY | GEFITINIB | ONCOLOGY | ADENOCARCINOMA | ACQUIRED-RESISTANCE | EGFR MUTATIONS | NONINVASIVE DETECTION | ASSOCIATION | CHEMOTHERAPY | Lung Neoplasms - genetics | Prospective Studies | Circulating Tumor DNA - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Genotype | Male | Mutation - genetics | Drug Resistance, Neoplasm - genetics | DNA, Neoplasm - blood | Aged, 80 and over | Adult | Female | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | High-Throughput Nucleotide Sequencing - methods | Index Medicus | lung cancer | Next-generation sequencing | liquid biopsy | circulating tumor DNA | personalized medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
by Tie, Jeanne and Wang, Yuxuan and Tomasetti, Cristian and Li, Lu and Springer, Simeon and Kinde, Isaac and Silliman, Natalie and Tacey, Mark and Wong, Hui-Li and Christie, Michael and Kosmider, Suzanne and Skinner, Iain and Wong, Rachel and Steel, Malcolm and Tran, Ben and Desai, Jayesh and Jones, Ian and Haydon, Andrew and Hayes, Theresa and Price, Tim J and Strausberg, Robert L and Diaz, Luis A and Papadopoulos, Nickolas and Kinzler, Kenneth W and Vogelstein, Bert and Gibbs, Peter
Science Translational Medicine, ISSN 1946-6234, 07/2016, Volume 8, Issue 346, pp. 346ra92 - 346ra92
Detection of circulating tumor DNA(ctDNA) after resection of stage II colon cancer may identify patients at the highest risk of recurrence and help inform... 
INTENSIVE FOLLOW-UP | ADJUVANT CHEMOTHERAPY | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | THERAPY | MARKER | COLORECTAL-CANCER | CALGB 9581 | ACQUIRED-RESISTANCE | MISMATCH REPAIR | FLUOROURACIL | CELL BIOLOGY | Circulating Tumor DNA - analysis | Colonic Neoplasms - genetics | Prospective Studies | Circulating Tumor DNA - genetics | Neoplasm, Residual - surgery | Humans | Proportional Hazards Models | Neoplasm, Residual - blood | Neoplasm, Residual - genetics | Colonic Neoplasms - surgery | Disease-Free Survival | Colonic Neoplasms - blood | Neoplasm Recurrence, Local - genetics | Neoplasm Staging | Neoplasm Recurrence, Local - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Nucleic acid detection with CRISPR-Cas13a/C2c2
by Gootenberg, Jonathan S and Abudayyeh, Omar O and Lee, Jeong Wook and Essletzbichler, Patrick and Dy, Aaron J and Joung, Julia and Verdine, Vanessa and Donghia, Nina and Daringer, Nichole M and Freije, Catherine A and Myhrvold, Cameron and Bhattacharyya, Roby P and Livny, Jonathan and Regev, Aviv and Koonin, Eugene V and Hung, Deborah T and Sabeti, Pardis C and Collins, James J and Zhang, Feng
Science, ISSN 0036-8075, 04/2017, Volume 356, Issue 6336, pp. 438 - 442
Rapid, inexpensive, and sensitive nucleic acid detection may aid point-of-care pathogen detection, genotyping, and disease monitoring. The RNA-guided,... 
CRISPR-CAS SYSTEMS | AMPLIFICATION | CIRCULATING TUMOR DNA | PROTEINS | MULTIDISCIPLINARY SCIENCES | ZIKA VIRUS | Circulating Tumor DNA - analysis | Zika Virus - genetics | Circulating Tumor DNA - genetics | Ribonucleases - chemistry | Humans | Bacterial Proteins - chemistry | RNA, Viral - analysis | RNA Cleavage | Zika Virus - isolation & purification | Dengue Virus - genetics | Bacteria - isolation & purification | RNA, Viral - genetics | Zika Virus Infection - diagnosis | Neoplasms - genetics | Point-of-Care Systems | Clustered Regularly Interspaced Short Palindromic Repeats | DNA, Bacterial - analysis | Bacteria - pathogenicity | Dengue Virus - isolation & purification | Mutation | Dengue - diagnosis | Methods | Nucleotide sequencing | DNA sequencing | Vector-borne diseases | Pathogens | CRISPR | Target recognition | Nucleotide sequence | Dengue | Viruses | Zika virus | Nucleic acids | Ribonuclease | Recombinase | Ribonucleic acid--RNA | Sensitivity | Genotyping | Reagents | Bacteria | Deoxyribonucleic acid--DNA | Index Medicus | Amplification | Ribonucleic acids | Deoxyribonucleic acid
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
by Xu, Rui-Hua and Wei, Wei and Krawczyk, Michal and Wang, Wenqiu and Luo, Huiyan and Flagg, Ken and Yi, Shaohua and Shi, William and Quan, Qingli and Li, Kang and Zheng, Lianghong and Zhang, Heng and Caughey, Bennett A and Zhao, Qi and Hou, Jiayi and Zhang, Runze and Xu, Yanxin and Cai, Huimin and Li, Gen and Hou, Rui and Zhong, Zheng and Lin, Danni and Fu, Xin and Zhu, Jie and Duan, Yaou and Yu, Meixing and Ying, Binwu and Zhang, Wengeng and Wang, Juan and Zhang, Edward and Zhang, Charlotte and Li, Oulan and Guo, Rongping and Carter, Hannah and Zhu, Jian-Kang and Hao, Xiaoke and Zhang, Kang
Nature Materials, ISSN 1476-1122, 10/2017, Volume 16, Issue 11, pp. 1155 - 1162
An effective blood-based method for the diagnosis and prognosis of hepatocellular carcinoma (HCC) has not yet been developed. Circulating tumour DNA (ctDNA)... 
OF-ORIGIN | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | MANAGEMENT | MATERIALS SCIENCE, MULTIDISCIPLINARY | ACQUIRED-RESISTANCE | CHEMISTRY, PHYSICAL | CANCER | LINKAGE DISEQUILIBRIUM | MODIFIED RECIST | HUMAN GENOME | MUTATIONS | ALPHA-FETOPROTEIN | Prognosis | Circulating Tumor DNA - genetics | Liver Neoplasms - genetics | Carcinoma, Hepatocellular - diagnosis | Humans | Male | Biomarkers, Tumor - blood | Liver Neoplasms - blood | DNA Methylation | Liver Neoplasms - diagnosis | Models, Biological | Carcinoma, Hepatocellular - genetics | Female | Biomarkers, Tumor - genetics | Carcinoma, Hepatocellular - blood | Circulating Tumor DNA - blood | Markers | Leukocytes | Medical diagnosis | Liver cancer | Medical prognosis | Hepatology | Predictions | DNA methylation | Diagnostic systems | Mathematical models | Diagnosis | Aberration | Methylation | Deoxyribonucleic acid--DNA | Cancer | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Hypermutated circulating tumor DNA: Correlation with response to checkpoint inhibitor–based immunotherapy
by Khagi, Yulian and Goodman, Aaron M and Daniels, Gregory A and Patel, Sandip P and Sacco, Assuntina G and Randall, James M and Bazhenova, Lyudmila A and Kurzrock, Razelle
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 19, pp. 5729 - 5736
Purpose: Tumor mutational burden detected by tissue next-generation sequencing (NGS) correlates with checkpoint inhibitor response. However, tissue biopsy may... 
ONCOLOGY | CLINICAL-RESPONSE | PD-1 BLOCKADE | Circulating Tumor DNA - genetics | Humans | Middle Aged | Genes, cdc - drug effects | Male | Neoplasms - drug therapy | Biomarkers, Tumor - blood | Disease-Free Survival | Neoplasms - blood | DNA, Neoplasm - blood | Neoplasms - genetics | Immunotherapy | Neoplasm Proteins | Aged, 80 and over | Adult | Female | Aged | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Circulating Tumor DNA - blood | Gene Expression Regulation, Neoplastic - drug effects | Mutation | Neoplasms - pathology | Statistical analysis | Invasiveness | Survival | Blood | Alterations | Inhibitors | Immune checkpoint | Blood circulation | Biopsy | Experimental design | Biomarkers | Bioindicators | Significance | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
by Annala, Matti and Struss, Werner J and Warner, Evan W and Beja, Kevin and Vandekerkhove, Gillian and Wong, Amanda and Khalaf, Daniel and Seppälä, Irma-Liisa and So, Alan and Lo, Gregory and Aggarwal, Rahul and Small, Eric J and Nykter, Matti and Gleave, Martin E and Chi, Kim N and Wyatt, Alexander W
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 1, pp. 34 - 42
Abstract Background Germline mutations in DNA repair genes were recently reported in 8–12% of patients with metastatic castration-resistant prostate cancer... 
Urology | Castration-resistant prostate cancer | Abiraterone | Cell-free DNA | Liquid biopsy | Enzalutamide | BRCA2 | DNA repair | Circulating tumor DNA | RISK | CHEMOTHERAPY | RESISTANCE | UROLOGY & NEPHROLOGY | MUTATIONS | Liquid Biopsy | Circulating Tumor DNA - genetics | Humans | Middle Aged | Male | Loss of Heterozygosity | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Time Factors | DNA Mutational Analysis | Antineoplastic Agents, Hormonal - therapeutic use | Germ-Line Mutation | Kallikreins - blood | Genetic Predisposition to Disease | Prostatic Neoplasms, Castration-Resistant - blood | Kaplan-Meier Estimate | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Disease Progression | Prostate-Specific Antigen - blood | Phenotype | DNA Repair | Androgen Antagonists - therapeutic use | Aged | Biomarkers, Tumor - genetics | Circulating Tumor DNA - blood | Androgen Antagonists - adverse effects | Biotechnology | Gene mutations | Patient outcomes | DNA | Genetic aspects | Metastasis | Drug therapy | Prostate cancer | Cancer | Antigens | Analysis | Genetic research | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
by Scherer, Florian and Kurtz, David M and Newman, Aaron M and Stehr, Henning and Craig, Alexander F. M and Esfahani, Mohammad Shahrokh and Lovejoy, Alexander F and Chabon, Jacob J and Klass, Daniel M and Liu, Chih Long and Zhou, Li and Glover, Cynthia and Visser, Brendan C and Poultsides, George A and Advani, Ranjana H and Maeda, Lauren S and Gupta, Neel K and Levy, Ronald and Ohgami, Robert S and Kunder, Christian A and Diehn, Maximilian and Alizadeh, Ash A
Science Translational Medicine, ISSN 1946-6234, 11/2016, Volume 8, Issue 364, pp. 364ra155 - 364ra155
Patients with diffuse large B cell lymphoma (DLBCL) exhibit marked diversity in tumor behavior and outcomes, yet the identification of poor-risk groups remains... 
RESISTANCE MECHANISMS | MOLECULAR SUBTYPES | MEDICINE, RESEARCH & EXPERIMENTAL | B-CELL LYMPHOMA | PARAFFIN-EMBEDDED TISSUE | GENE-EXPRESSION | NON-HODGKIN-LYMPHOMA | FOLLICULAR LYMPHOMA | PROGNOSTIC-SIGNIFICANCE | ELDERLY-PATIENTS | SOMATIC MUTATIONS | CELL BIOLOGY | Recurrence | Prognosis | Circulating Tumor DNA - genetics | Lymphoma, B-Cell - blood | Humans | Middle Aged | Genotype | Male | Treatment Outcome | Lymphoma, B-Cell - genetics | Biomarkers, Tumor - blood | Immunoglobulins - chemistry | Algorithms | Cell-Free System | Lymphoma, Large B-Cell, Diffuse - blood | Biopsy | Aged, 80 and over | Adult | Female | Aged | Mutation | Lymphoma, Large B-Cell, Diffuse - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
by O'Leary, Ben and Hrebien, Sarah and Morden, James P and Beaney, Matthew and Fribbens, Charlotte and Huang, Xin and Liu, Yuan and Bartlett, Cynthia Huang and Koehler, Maria and Cristofanilli, Massimo and Garcia-Murillas, Isaac and Bliss, Judith M and Turner, Nicholas C
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 896 - 10
CDK4/6 inhibition substantially improves progression-free survival (PFS) for women with advanced estrogen receptor-positive breast cancer, although there are... 
TRIAL | EVOLUTION | PLASMA | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | ESR1 MUTATIONS | DOUBLE-BLIND | EGFR MUTATIONS | THERAPEUTIC RESPONSE | INHIBITORS | NSCLC PATIENTS | Estradiol - analogs & derivatives | Receptors, Estrogen - metabolism | Class I Phosphatidylinositol 3-Kinases - genetics | Receptors, Estrogen - genetics | Circulating Tumor DNA - genetics | Class I Phosphatidylinositol 3-Kinases - metabolism | Estradiol - therapeutic use | Humans | Cyclin-Dependent Kinase 6 - genetics | Antineoplastic Agents - therapeutic use | Cyclin-Dependent Kinase 6 - metabolism | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Fulvestrant | Disease-Free Survival | Circulating Tumor DNA - metabolism | Breast Neoplasms - genetics | Female | Pyridines - therapeutic use | Estrogens | Estrogen receptors | Breast cancer | Cyclin-dependent kinase 4 | Dynamics | Predictions | Biomarkers | Breast | Clonal selection | Bioindicators | Mutation | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Use of liquid biopsies in clinical oncology: Pilot experience in 168 patients
by Schwaederle, Maria and Husain, Hatim and Fanta, Paul T and Piccioni, David E and Kesari, Santosh and Schwab, Richard B and Patel, Sandip P and Harismendy, Olivier and Ikeda, Megumi and Parker, Barbara A and Kurzrock, Razelle
Clinical Cancer Research, ISSN 1078-0432, 11/2016, Volume 22, Issue 22, pp. 5497 - 5505
Purpose: There is a growing interest in using circulating tumor DNA (ctDNA) testing in patients with cancer. Experimental Design: A total of 168 patients with... 
PLASMA | THERAPY | CIRCULATING TUMOR DNA | ONCOLOGY | COLORECTAL-CANCER | METASTATIC BREAST-CANCER | INTRATUMOR HETEROGENEITY | UNIVERSITY-OF-CALIFORNIA | ACTIONABLE MUTATIONS | CELL-FREE DNA | BLOOD | Medical Oncology - methods | Receptor, Epidermal Growth Factor - genetics | Circulating Tumor DNA - genetics | Receptor, ErbB-2 - genetics | Liquid Biopsy - methods | Genomics | Humans | Middle Aged | Male | Tumor Suppressor Protein p53 - genetics | Phosphatidylinositol 3-Kinases - genetics | Neoplasms - blood | DNA, Neoplasm - blood | Neoplasms - genetics | Female | Retrospective Studies | Circulating Tumor DNA - blood | DNA, Neoplasm - genetics | High-Throughput Nucleotide Sequencing - methods | Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Circulating cell-free tumor DNA analysis of 50 genes by next-generation sequencing in the prospective MOSCATO trial
by Jovelet, Cécile and Ileana, Ecaterina and Le Deley, Marie-Cécile and Motté, Nelly and Rosellini, Silvia and Romero, Alfredo and Lefebvre, Celine and Pedrero, Marion and Pata-Merci, Noémie and Droin, Nathalie and Deloger, Marc and Massard, Christophe and Hollebecque, Antoine and Ferté, Charles and Boichard, Amélie and Postel-Vinay, Sophie and Ngo-Camus, Maud and De Baere, Thierry and Vielh, Philippe and Scoazec, Jean-Yves and Vassal, Gilles and Eggermont, Alexander and André, Fabrice and Soria, Jean-Charles and Lacroix, Ludovic
Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2960 - 2968
Purpose: Liquid biopsies based on circulating cell-free DNA (cfDNA) analysis are described as surrogate samples for molecular analysis. We evaluated the... 
HETEROGENEITY | EVOLUTION | ONCOLOGY | METASTATIC BREAST-CANCER | PLASMA DNA | BIOPSY | RESISTANCE | OPTIMIZATION | PERSONALIZED MEDICINE | BLOOD | Prospective Studies | Circulating Tumor DNA - genetics | Humans | Middle Aged | Male | DNA Mutational Analysis - methods | Molecular Targeted Therapy | Patient Selection | Biomarkers, Tumor - blood | Young Adult | Neoplasms - blood | DNA, Neoplasm - blood | Neoplasms - genetics | Adolescent | Adult | Female | Aged | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | DNA, Neoplasm - genetics | Mutation | Clinical Trials, Phase I as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Concordance of genomic alterations by next-generation sequencing in tumor tissue versus circulating tumor DNA in breast cancer
by Chae, Young Kwang and Davis, Andrew A and Jain, Sarika and Santa-Maria, Cesar and Flaum, Lisa and Beaubier, Nike and Platanias, Leonidas C and Gradishar, William and Giles, Francis J and Cristofanilli, Massimo
Molecular Cancer Therapeutics, ISSN 1535-7163, 07/2017, Volume 16, Issue 7, pp. 1412 - 1420
While identifying genomic alterations in tumor tissue is the current gold-standard technique for molecular profiling, circulating tumor DNA (ctDNA) represents... 
SURVIVAL | THERAPY | PLASMA | ONCOLOGY | INTRATUMOR HETEROGENEITY | ESR1 MUTATIONS | RESISTANCE | LIQUID BIOPSIES | CELL-FREE DNA | DISEASE PROGRESSION | BLOOD | Class I Phosphatidylinositol 3-Kinases - genetics | Circulating Tumor DNA - genetics | Receptor, ErbB-2 - genetics | Genomics | Humans | Middle Aged | Male | Tumor Suppressor Protein p53 - genetics | BRCA1 Protein - genetics | Breast Neoplasms - genetics | Biopsy | Breast Neoplasms - pathology | Breast Neoplasms - blood | Cell Line, Tumor | Female | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Circulating Tumor DNA - blood | Mutation | Genome, Human | BRCA2 Protein - genetics | BRCA2 protein | BRCA1 protein | p53 Protein | Genes | Spatial discrimination | Breast cancer | ErbB-2 protein | Blood | Contamination | Gene sequencing | Alterations | Gene frequency | Peripheral blood | Breast | DNA fingerprinting | Deoxyribonucleic acid--DNA | DNA sequencing | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
by Kis, Olena and Kaedbey, Rayan and Chow, Signy and Danesh, Arnavaz and Dowar, Mark and Li, Tiantian and Li, Zhihua and Liu, Jessica and Mansour, Mark and Masih-Khan, Esther and Zhang, Tong and Bratman, Scott V and Oza, Amit M and Kamel-Reid, Suzanne and Trudel, Suzanne and Pugh, Trevor J
Nature Communications, ISSN 2041-1723, 2017, Volume 8, Issue 1, pp. 15086 - 15086
The requirement for bone-marrow aspirates for genomic profiling of multiple myeloma poses an obstacle to enrolment and retention of patients in clinical... 
CELL LUNG-CANCER | DIAGNOSIS | IMPACT | TRAMETINIB | MULTIDISCIPLINARY SCIENCES | MUTATIONS | SAMPLES | PLASMA-CELLS | Receptor, Epidermal Growth Factor - genetics | Class I Phosphatidylinositol 3-Kinases - genetics | Circulating Tumor DNA - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Proto-Oncogene Proteins p21(ras) - blood | Sensitivity and Specificity | Class I Phosphatidylinositol 3-Kinases - blood | Receptor, Epidermal Growth Factor - blood | Membrane Proteins - blood | Multiple Myeloma - blood | Multiple Myeloma - diagnosis | Membrane Proteins - genetics | Gene Frequency | Bone Marrow Cells - pathology | Proto-Oncogene Proteins B-raf - blood | Sequence Analysis, DNA | Biomarkers, Tumor - blood | Multiple Myeloma - pathology | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Alleles | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Circulating Tumor DNA - blood | GTP Phosphohydrolases - blood | Mutation | Biopsy - ethics | Bone Marrow Cells - metabolism | Multiple Myeloma - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Detection and localization of surgically resectable cancers with a multi-analyte blood test
by Cohen, Joshua D and Li, Lu and Wang, Yuxuan and Thoburn, Christopher and Afsari, Bahman and Danilova, Ludmila and Douville, Christopher and Javed, Ammar A and Wong, Fay and Mattox, Austin and Hruban, Ralph. H and Wolfgang, Christopher L and Goggins, Michael G and Molin, Marco Dal and Wang, Tian-Li and Roden, Richard and Klein, Alison P and Ptak, Janine and Dobbyn, Lisa and Schaefer, Joy and Silliman, Natalie and Popoli, Maria and Vogelstein, Joshua T and Browne, James D and Schoen, Robert E and Brand, Randall E and Tie, Jeanne and Gibbs, Peter and Wong, Hui-Li and Mansfield, Aaron S and Jen, Jin and Hanash, Samir M and Falconi, Massimo and Allen, Peter J and Zhou, Shibin and Bettegowda, Chetan and Diaz, Luis A and Tomasetti, Cristian and Kinzler, Kenneth W and Vogelstein, Bert and Lennon, Anne Marie and Papadopoulos, Nickolas
Science, ISSN 0036-8075, 02/2018, Volume 359, Issue 6378, pp. 926 - 930
Earlier detection is key to reducing cancer deaths. Here, we describe a blood test that can detect eight common cancer types through assessment of the levels... 
BIOMARKERS | LUNG-CANCER | EVOLUTION | CIRCULATING TUMOR DNA | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | MUTATIONS | Early Detection of Cancer - economics | Costs and Cost Analysis | Circulating Tumor DNA - genetics | Early Detection of Cancer - methods | Neoplasms - surgery | Humans | Neoplasms - diagnosis | Polymerase Chain Reaction - methods | Neoplasms - blood | Neoplasms - genetics | Hematologic Tests - economics | Neoplasm Proteins - blood | Mutation | Medical examination | Diagnosis | Methods | Blood | Ovarian cancer | Cancer | Stomach | Liver | Lung | Biological evolution | Blood tests | Health risks | Patients | Esophagus | Proteins | Liver cancer | Sensitivity | Surgery | Biomarkers | Bioindicators | Pancreas | Localization | Evolution & development | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights